MA
| Title | Published in | Access level | OA Policy | Year | Views | Downloads | |
|---|---|---|---|---|---|---|---|
| Chromatin regulators in the TBX1 network confer risk for conotruncal heart defects in 22q11.2DS | npj genomic medicine |  | 2023 | 104 | 40 | ||
| La maturation cérébrale chez les jeunes et la transition des patients consultants en pédopsychiatrie: y-a-t-il une incohérence? | Cahiers de psychologie clinique | | 2021 | 302 | 1,343 | ||
| Impact de la pandémie de Covid-19 sur les troubles psychiques des adolescents et jeunes adultes | Revue médicale suisse | | 2021 | 13 | 62 | ||
| Using common genetic variation to examine phenotypic expression and risk prediction in 22q11.2 deletion syndrome | Nature Medicine |  | 2020 | 356 | 0 | ||
| Complete Sequence of the 22q11.2 Allele in 1,053 Subjects with 22q11.2 Deletion Syndrome Reveals Modifiers of Conotruncal Heart Defects | American Journal of Human Genetics | | 2020 | 433 | 0 | ||
| Associations between schizotypal personality features, mentalizing difficulties and thought problems in a sample of community adolescents | Early Intervention in Psychiatry | | 2020 | 394 | 339 | ||
| Favorable effects of omega-3 polyunsaturated fatty acids in attentional control and conversion rate to psychosis in 22q11.2 deletion syndrome | Neuropharmacology |  | 2020 | 504 | 3 | ||
| Pituitary dysmaturation affects psychopathology and neurodevelopment in 22q11.2 Deletion Syndrome | Psychoneuroendocrinology | | 2020 | 444 | 596 | ||
| Genetic contributors to risk of schizophrenia in the presence of a 22q11.2 deletion | Molecular Psychiatry | | 2020 | 426 | 3 | ||
| 22q11 microdeletion syndrome and ultra-high risk for psychosis: The role of neurological soft signs as an independent marker of vulnerability for psychosis | Early Intervention in Psychiatry | | 2019 | 336 | 1 | ||
| Antipsychotics do not influence neurological soft signs in children and adolescents at ultra-high risk for psychosis: a pilot study | Journal of psychiatric practice | | 2019 | 311 | 1 | ||
| Prevalence of Non-Affective Psychoses in Individuals with Autism Spectrum Disorders: A Systematic Review | Journal of Clinical Medicine | | 2019 | 348 | 335 | ||
| Attention deficit hyperactivity disorder symptoms as antecedents of later psychotic outcomes in 22q11.2 deletion syndrome | Schizophrenia Research | | 2019 | 380 | 164 | ||
| Prevalence, course and psychosis-predictive value of negative symptoms in 22q11.2 deletion syndrome | Schizophrenia Research | | 2019 | 536 | 438 | ||
| Individualized prediction of transition to psychosis in 1,676 individuals at clinical high risk: development and validation of a multivariable prediction model based on individual patient data meta-analysis | Frontiers in Psychiatry | | 2019 | 329 | 287 | ||
| A Mentalization-Informed Staging Approach to Clinical High Risk for Psychosis | Frontiers in Psychiatry | | 2019 | 379 | 387 | ||
| Prevalence and Clinical Significance of Symptoms at Ultra High Risk for Psychosis in Children and Adolescents with Obsessive⁻Compulsive Disorder: Is There an Association with Global, Role, and Social Functioning? | Brain Sciences | | 2018 | 595 | 279 | ||
| Coping Strategies Mediate the Effect of Stressful Life Events on Schizotypal Traits and Psychotic Symptoms in 22q11.2 Deletion Syndrome | Schizophrenia Bulletin | | 2018 | 563 | 5 | ||
| Variance of IQ is partially dependent on deletion type among 1,427 22q11.2 deletion syndrome subjects | American Journal of Medical Genetics. A | | 2018 | 403 | 303 | ||
| Cortical morphology development in patients with 22q11.2 deletion syndrome at ultra-high risk of psychosis | Psychological Medicine | | 2018 | 608 | 205 | ||
| Understanding the pediatric psychiatric phenotype of 22q11.2 deletion syndrome | American Journal of Medical Genetics. A | | 2018 | 482 | 1 | ||
| Variations in Dysbindin-1 are associated with cognitive response to antipsychotic drug treatment | Nature Communications | | 2018 | 534 | 208 | ||
| Adolescence is the starting point of sex-dichotomous COMT genetic effects | Translational Psychiatry | | 2017 | 486 | 253 | ||
| Clinical presentation of Attenuated Psychosis Syndrome in children and adolescents: Is there an age effect? | Psychiatry Research | | 2017 | 444 | 2 | ||
| No evidence for the presence of genetic variants predisposing to psychotic disorders on the non-deleted 22q11.2 allele of VCFS patients | Translational Psychiatry | | 2017 | 631 | 220 | ||
| Détection et traitement précoce des sujets à haut risque clinique depsychose : définitions et recommandations | L'encéphale | | 2017 | 704 | 13 | ||
| The contribution of a neurodevelopment and genetic perspective to our understanding of the pathogenesis of psychotic disorders: the case of 22q11ds and of youth populations | | 2017 | 484 | 7 | |||
| Subthreshold Psychosis in 22q11.2 Deletion Syndrome: Multisite Naturalistic Study | Schizophrenia bulletin | | 2017 | 566 | 0 | ||
| No age effect in the prevalence and clinical significance of ultra-high risk symptoms and criteria for psychosis in 22q11 deletion syndrome: Confirmation of the genetically driven risk for psychosis? | PLOS ONE | | 2017 | 544 | 289 | ||
| Ultra high risk status and transition to psychosis in 22q11.2 deletion syndrome | World Psychiatry | | 2016 | 509 | 0 | ||
| Cognitive Decline Preceding the Onset of Psychosis in Patients With 22q11.2 Deletion Syndrome | JAMA psychiatry | | 2015 | 701 | 1,268 | ||
| Psychiatric Disorders From Childhood to Adulthood in 22q11.2 Deletion Syndrome: Results From the International Consortium on Brain and Behavior in 22q11.2 Deletion Syndrome | The American journal of psychiatry | | 2014 | 996 | 8 | ||
| Enhanced maternal origin of the 22q11.2 deletion in velocardiofacial and DiGeorge syndromes | American journal of human genetics | | 2013 | 711 | 3 |
